These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17034119)

  • 21. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
    Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
    Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
    Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway.
    Xu X; Li Q; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(2):321-6. PubMed ID: 24140409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
    Swahn BM; Macsari I; Viklund J; Ohberg L; Sjödin J; Neelissen J; Lindquist J
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2009-12. PubMed ID: 19264481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LXR agonists for the treatment of atherosclerosis.
    Jaye M
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1053-8. PubMed ID: 14582448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
    Wong J; Quinn CM; Brown AJ
    Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Padovani AM; Molina MF; Mann KK
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.
    Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR
    Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
    Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
    Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
    Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
    Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
    Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in the study of anti-atherosclerosis drugs].
    Guo CB; Li S
    Yao Xue Xue Bao; 2007 Mar; 42(3):231-5. PubMed ID: 17520819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists.
    Bernotas RC; Kaufman DH; Singhaus RR; Ullrich J; Unwalla R; Quinet E; Nambi P; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem; 2009 Dec; 17(23):8086-92. PubMed ID: 19853462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis.
    Zhao JF; Ching LC; Huang YC; Chen CY; Chiang AN; Kou YR; Shyue SK; Lee TS
    Mol Nutr Food Res; 2012 May; 56(5):691-701. PubMed ID: 22648616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptors regulate adrenal cholesterol balance.
    Cummins CL; Volle DH; Zhang Y; McDonald JG; Sion B; Lefrançois-Martinez AM; Caira F; Veyssière G; Mangelsdorf DJ; Lobaccaro JM
    J Clin Invest; 2006 Jul; 116(7):1902-12. PubMed ID: 16823488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver-X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-2 cells: effect on cholesterol efflux to high-density lipoprotein.
    Murthy S; Born E; Mathur SN; Field FJ
    Biochem J; 2004 Feb; 377(Pt 3):545-52. PubMed ID: 14604434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis.
    Lund EG; Menke JG; Sparrow CP
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1169-77. PubMed ID: 12615685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.